Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors
HTL will build, validate and operate a botulinum manufacturing facility in the US
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
ABB Drives play a key role in the cleanroom infrastructure of Bharat Biotech, India’s first indigenous Covid-19 vaccine manufacturer. The drives are easy to commission, use and ensure higher energy efficiency
The facility has the capacity to produce one crore doses per day
The company to receive upfront and milestone payments, in addition to royalties
This is the first of its kind vaccine for Covid 19 to get the go-ahead
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
A veteran in cell therapy and oncology commercialisation
Subscribe To Our Newsletter & Stay Updated
